Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk

Brain Research

Volumn 1280, Issue , 2009, Pages 166-171

  Rodríguez Rodríguez, Eloy ^a   Mateo, Ignacio ^a   Infante, Jon ^a   Llorca, Javier ^b   García Gorostiaga, Inés ^a   Vázquez Higuera, José Luis ^a   Sánchez Juan, Pascual ^a   Berciano, José ^a   Combarros, Onofre ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

ABCA1; Alzheimer's disease; Cholesterol; HMGCR; Polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE; GENE INTERACTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; RISK; SEX; SPAIN; SYNTHESIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 67649649934     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.05.019     Document Type: Article

References (23)

1. Björkhem I., and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 806-815
2. Combarros, O., Cortina-Borja, M., Smith, A.D., Lehmann, D.J., 2008. Epistasis in sporadic Alzheimer's disease. Neurobiol. Aging (epub ahead of print; doi: 10.1016/j.neurobiolaging.2007.11.027).
3. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12 (2001) 105-112
4. González J.R., Carrasco J.L., Dudbridge F., Armengol L., Estivill X., and Moreno V. Maximizing association statistics over genetic models. Genet. Epidemiol. 32 (2008) 246-254
5. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachman D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
6. Katzov H., Chalmers K., Palmgren J., Andreasen N., Johansson B., Cairns N.J., Gatz M., Wilcock G.K., Love S., Pedersen N.L., Brookes A.J., Blennow K., Kehoe P.G., and Prince J.A. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β-amyloid metabolism. Hum. Mutat. 23 (2004) 358-367
7. Koldamova R., Staufenbiel M., and Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 280 (2005) 43224-43235
8. Kölsch H., Lütjohann D., Jessen F., Von Bergmann K., Schmitz S., Urbach H., Maier W., and Heun R. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. Int. J. Mol. Med. 17 (2006) 791-794
9. Kyriakou T., Hodgkinson C., Pontefract D.E., Iyengar S., Howell W.M., Wong Y., Eriksson P., and Ye S. Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 418-423
10. Li G., Larson E.B., Sonnen J.A., Shofer J.B., Petrie E.C., Schantz A., Peskind E.R., Raskind M.A., Breitner J.C.S., and Montine TJ. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69 (2007) 878-885
11. Llorca J., Dierssen-Sotos T., Combarros O., and Berciano J. Consistency in gene-Alzheimer's disease association studies. J. Epidemiol. Community Health 59 (2005) 83-85
12. Masse I., Bordet R., Deplanque D., Al Khedr A., Richard F., Libersa C., and Pasquier F. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1624-1629
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 24 (1984) 939-944
14. Porcellini E., Calíbrese E., Guerini F., Govoni M., Chiappelli M., Tumini E., Morgan K., Chappell S., Kalsheker N., Franceschi M., and Licastro F. The hydroxyl-methylglutaryl-coenzyme A reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration. Neurosci. Lett. 416 (2007) 66-70
15. Puglielli L., Tanzi R.E., and Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6 (2003) 345-351
16. Rodríguez-Rodríguez E., Mateo I., Llorca J., Sánchez-Quintana C., Infante J., García-Gorostiaga I., Sánchez-Juan P., Berciano J., and Combarros O. Association of genetic variants of ABCA1 with Alzheimer's disease risk. Am. J. Med. Genet. 144B (2007) 964-968
17. Shobab L.A., Hsiung G.Y., and Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol. 4 (2005) 841-852
18. Sparks L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Browne P., Wasser D., Johnson-Traver S., Lochhead J., and Ziolwolski C. Atorvastatin for the treatment of mild to moderate Alzheimer disease. Arch. Neurol. 62 (2005) 753-7757
19. Sundar P.D., Feingold E., Minster R.L., DeKosky S.T., and Kamboh M.I. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol. Aging 28 (2007) 856-862
20. Wahrle S.E., Jiang H., Parsadanian M., Hartman R.E., Bales K.R., Paul S.M., and Holtzman D.M. Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease. J. Biol. Chem. 280 (2005) 43236-43242
21. Wavrant-De Vrièze F., Compton D., Womick M., Arepalli S., Adighibe O., Li P., Pérez-Tur J., and Hardy J. ABCA1 polymorphisms and Alzheimer's disease. Neurosci. Lett. 416 (2007) 180-183
22. Wolozin B., Kellman W., Ruosseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443
23. Yasojima K., McGeer E.G., and McGeer P.L. 3-hydroxy-3-methylglutaryl-coenzyme A reductase MRNA in Alzheimer and control brain. NeuroReport 12 (2001) 2935-2938